drugset / Trial / NCT01476449

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

NCT01476449

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to see whether treating diabetic retinal swelling with ranibizumab injections into the eye monthly is better than treating diabetic retinal swelling with ranibizumab injections into the eye less frequently.

Timeline

Start
2011-11
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranibizumab Monoclonal antibody 0.5 mg Intravitreal